$VICR

VINCIARELLI PATRIZIO sold $204K of VICR

VINCIARELLI PATRIZIO (Chairman and CEO) sold 600 shares of VICOR CORP (VICR) at $340.25 ($0.20M total) on 2026-05-28 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · VINCIARELLI PATRIZIO
Published May 29, 2026, 6:44 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 29, 2026, 7:14 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

The CEO/Chairman sold shares at ~$340.25/share; the presence of a pre-arranged 10b5-1 plan suggests planned selling rather than new information.

02

Market read

Traders may note insider selling, but the 10b5-1 structure typically limits interpretive value for near-term fundamentals.

03

What to watch

The filing doesn’t disclose motivations or whether other insiders are buying; without follow-on transactions, the signal is weak.

Relevance 6/10Novelty 4/10Timing: SEC Form 4 filed May 29 (covers sale executed May 28)

Background

The article is an SEC Form 4 insider transaction disclosure for Vicor (VICR).

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

VICR’s Chairman/CEO sold 600 shares in an open-market transaction disclosed via SEC Form 4 on May 28 under a 10b5-1 plan.

Expected impact

Likely limited near-term price impact; any effect is more sentiment/flow-related than fundamental.

Evidence & confidence

The filing provides a concrete transaction and price, but the 10b5-1 pre-arrangement typically indicates routine planned selling rather than new negative information.

Market effects

Minimal; this is company-specific insider activity with no stated operational/regulatory catalyst.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect diversification/compensation mechanics rather than bearish expectations.

Key entities

  • VICOR CORP

    Subject of the SEC Form 4 insider transaction disclosure.

  • VINCIARELLI PATRIZIO

    Chairman and CEO (10% owner) who executed the open-market sale under a 10b5-1 plan.

Related articles

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: